Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intrathecal umbilical cord blood-derived oligodendrocyte-like cells for several inherited metabolic brain diseases; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UCB-derived oligodendrocyte-like cells (intrathecal)

Snippet

Sponsor: Joanne Kurtzberg, MD | Conditions: Adrenoleukodystrophy, Batten Disease | Phase 1 | Status: RECRUITING